Proposing norms for clinical application of biological radiolabelled compunds. pharmacodynamic and toxicological recommendations for preclinical studies
In October of 2005 a small group of researchers from different Countries had a meeting at the International Atomic Energy Agency headquarter in Vienna, Austria; the aim was to prepare a tentative user-friendly document for personnel involved in preparation of radiopharmaceuticals based on peptides,...
Main Author: | Ángel Casacó Parada |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)
2007-01-01
|
Series: | Nucleus |
Online Access: | http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/495 |
Similar Items
-
The use of chiral auxiliaries in the synthesis of chemically and biologically important chiral compunds
by: Bixa, Thobela Lukas
Published: (2014) -
Antimicrobial packaging with natural compunds - a review
by: Renata Dobrucka
Published: (2016-12-01) -
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
by: Lieke Joosten, et al.
Published: (2017-05-01) -
Pharmacokinetic-Pharmacodynamic Evaluations and Experimental Design Recommendations for Preclinical Studies of Anti-tuberculosis Drugs
by: Chen, Chunli
Published: (2017) -
Natural and synthetic compunds regulate the differentiation of preadipocytes to adipocytes
by: Tsai-Yun Chan, et al.
Published: (2019)